Predicting Lifescience
Startup Success
Analysis of 150 companies over 10 years and the key factors predicting lifescience startup success presented at Medical Device Playbook Newport Beach 2024 and on Livestream.
Mickey Urdea, founder and partner of Halteres Associates, at Medical Device Playbook Newport Beach 2024 takes an in-depth look at 150 lifescience startups over a period of 10 years and pinpoints the factors that predict whether a startup will succeed.
Predicting Lifescience Startup Success highlights include:
- Bill & Melinda Gates Foundation (BMGF) Project
- Diagnostics Company Success Metrics
- Growth Phases
- Results by Development Phase and Subphase
- Where Do Diagnostics Companies Fail?
- Useful Scoring of the Companies Studied
- Best Practices, Continuous Assessment of Risks and Mitigations
Presenter Bio
Mickey Urdea
Dr. Urdea is Founder and Partner for Halteres Associates. He also founded and served as Chief Executive Officer of Tethys Bioscience, a proteomics-based diagnostics company that has been involved in the prevention of type-2 diabetes (assets acquired by HDL), and was CEO of Quantum Dots Corporation (assets acquired by Life Technologies). Additionally, Dr. Urdea is a founder and the Chairman of Catalysis Foundation for Health (CFH), a non-profit organization addressing gaps in global healthcare caused by inefficiencies in disease diagnosis and monitoring; CFH is developing potential biomarkers for tuberculosis bacterial load with a grant for the Bill & Melinda Gates Foundation. Dr. Urdea is a member of the University of California at San Francisco Leadership Council for Global Health. He serves as a consultant to the life sciences industry and is on the scientific advisory boards and boards of directors of a number of biotechnology and diagnostics companies. Prior to his current activities, Dr. Urdea founded the Nucleic Acid Diagnostics business at Chiron Corporation, where he pioneered viral load assays for the human hepatitis B, hepatitis C and immunodeficiency viruses; his team introduced the first commercial viral load assays for all three viruses. Dr. Urdea also headed the Oncology Diagnostics business unit at Chiron. He then became business head of the Molecular Diagnostics group and Chief Scientific Officer at Bayer Diagnostics. He has served as an advisor to the Bill & Melinda Gates Foundation for over ten years. Dr. Urdea is an author on over 200 peer-reviewed scientific publications and has more than 125 issued and pending patents. He received his BS in Biology and Chemistry from Northern Arizona University, his PhD in Biochemistry from Washington State University, and had an NIH postdoctoral fellowship at the University of California at San Francisco. Read Dr. Urdea’s commencement address to the 2010 graduating class at Washington State University.
Medical Device Playbook is one of North America’s largest MedTech events for entrepreneurial companies and medical device professionals. Designed to inform and inspire medtech and biotech entrepreneurs, Playbook brings you stories and insights from some of the industry’s most remarkable entrepreneurs and seasoned experts.
StarFish Medical provides award-winning design, development, commercialization, and flexible manufacturing outsourcing services —100% dedicated to the medical device and life science marketplace. StarFish Medical partners with innovative companies to create and manufacture breakthrough products for a full range of medical specialty areas including: Digital Health, Cardiovascular, Neurology, Urology, Gastroenterology, Otology, Ophthalmology, and In-Vitro Diagnostics.
StarFish Medical’s technical expertise includes electronics, mechanical, software/firmware systems engineering, in addition to industrial design and human factors. Regulatory Affairs (RA) and Quality Assurance (QA) consultants at StarFish Medical provide regulatory assistance for FDA, CE Mark and Health Canada submissions. Services include QA support for setting up QMS for start-up companies with implementation at the client’s site, and assisting with ISO 13485 certification audits.
Empowering MedTech Innovation®. www.starfishmedical.com
Contact Patrick Dean, Director of Marketing, for media inquiries.